Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Depreciation & Amortization (CF) (2012 - 2026)

Kamada's (KMDA) quarterly Depreciation & Amortization (CF) came in at $3.9 million in Q2 2026, up 3.87% on a YoY basis from $3.7 million in Q2 2025, and up 1.04% quarter-over-quarter from $3.9 million in Q1 2026.

Analysis

Kamada (KMDA) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Depreciation & Amortization (CF) for 15 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Depreciation & Amortization (CF) rose 3.87% year-over-year to $3.9 million; the trailing twelve-month figure through Jun 2026 stood at $15.3 million (up 4.11% YoY), and the FY2025 full-year result was $14.9 million, up 8.04% from the prior year.
  • Depreciation & Amortization (CF) improved to $3.9 million in Q2 2026 per KMDA's latest filing, from $3.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $4.1 million in Q4 2024 and bottomed at $3.0 million in Q4 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $3.4 million across 5 years, with a median of $3.2 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 163.91% in 2022, then dropped 7.29% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $3.0 million in 2022, then advanced by 6.51% to $3.2 million in 2023, then advanced by 27.81% to $4.1 million in 2024, then decreased by 7.29% to $3.8 million in 2025, then gained by 2.37% to $3.9 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $3.9 million, $3.9 million, and $3.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 1.11 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 56.50 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 123.70 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 236.10 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 600,000.00
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn 3.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.89 Mn
Mar 31, 2026 3.85 Mn
Dec 31, 2025 3.80 Mn
Sep 30, 2025 3.76 Mn
Jun 30, 2025 3.75 Mn
Mar 31, 2025 3.61 Mn
Dec 31, 2024 4.10 Mn
Sep 30, 2024 3.24 Mn
Jun 30, 2024 3.23 Mn
Mar 31, 2024 3.24 Mn
Dec 31, 2023 3.21 Mn
Sep 30, 2023 3.18 Mn
Jun 30, 2023 3.20 Mn
Mar 31, 2023 3.12 Mn
Dec 31, 2022 3.01 Mn
Sep 30, 2022 3.06 Mn
Jun 30, 2022 3.06 Mn
Mar 31, 2022 3.03 Mn
Dec 31, 2021 2.00 Mn
Sep 30, 2021 1.24 Mn